A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
for EDS
14 locations incl. Peoria
Sponsor: Harmony Biosciences Management, Inc.
Sex: All·Age: 18+
Code: NCT07675135·Phase 3·Recruiting·Listed Jun 30, 2026
Cancer Therapy and Research Center (CTRC)
Clinical research site in San Antonio, Texas · 7979 WURZBACH RD, SAN ANTONIO, TX 78229-4427 · (210) 450-1000
As of July 2026, 11 paid clinical trials are recruiting at Cancer Therapy and Research Center (CTRC) in San Antonio, Texas. Active studies at this site cover conditions such as EDS, Cataplexy and Fatigue. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Cancer Therapy and Research Center (CTRC) (11)
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
for Obesity
17 locations incl. San Diego
Sponsor: Novo Nordisk A/S
Sex: All·Age: 18+
Code: NCT07571005·Phase 3·Recruiting·Listed May 2026
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
for Obesity
20 locations incl. Gilbert
Sponsor: Novo Nordisk A/S
Sex: All·Age: 18+
Code: NCT07571109·Phase 3·Recruiting·Listed May 2026
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
for Narcolepsy
17 locations incl. Santa Ana
Sponsor: Eisai Inc.
Sex: All·Age: 18+
Code: NCT07493265·Phase 2·Recruiting·Listed Mar 2026
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
for Meningioma
12 locations incl. Birmingham
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT07428616·Phase 2·Recruiting·Listed Feb 2026
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
for Sleep Apnea, Obstructive
23 locations incl. Cullman
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07369011·Phase 3·Recruiting·Listed Jan 2026
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
for Obesity
13 locations incl. Northridge
Sponsor: Amgen
Sex: All·Age: 18 - 99
Code: NCT07225686·Phase 3·Recruiting·Listed Nov 2025
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy
for Obstructive Sleep Apnea
13 locations incl. Northridge
Sponsor: Amgen
Sex: All·Age: 18 - 99
Code: NCT07226765·Phase 3·Recruiting·Listed Nov 2025
A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions
for Narcolepsy Type 1
19 locations incl. Birmingham
Sponsor: Takeda
Sex: All·Age: 16 - 70
Code: NCT05816382·Phase 2, Phase 3·Recruiting·Listed Apr 2023
A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors
for Advanced Solid Tumor
13 locations incl. Phoenix
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All·Age: 18+
Code: NCT06859762·Phase 1·Recruiting·Listed Mar 2025
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
for Advanced Solid Tumors
9 locations incl. Orlando
Sponsor: NextCure, Inc.
Sex: All·Age: 18+
Code: NCT06792552·Phase 1·Recruiting·Listed Jan 2025
More research sites in San Antonio
- University of Texas Health Science Center at San Antonio (85 trials)
- NEXT Oncology (56 trials)
- Children's Hospital of San Antonio (32 trials)
- Methodist Children's Hospital of South Texas (24 trials)
- START San Antonio (22 trials)
- The University of Texas Health Science Center at San Antonio (21 trials)
- UT Health San Antonio (16 trials)
- GSK Investigational Site (13 trials)
- Texas Dermatology and Laser Specialists (13 trials)
- Texas Oncology - San Antonio (12 trials)
Explore more
Paid clinical trials in San Antonio, TX · Texas clinical trials